Centalun was developed by Boehringer Ingelheim in 1962 and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABA_A receptor. It was previously used for sedation in medical procedures such as surgery, orthopedics and gynecology, although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the

CSA CSA may refer to: Arts and media * Canadian Screen Awards, annual awards given by the Academy of Canadian Cinema & Television * Commission on Superhuman Activities, a fictional American government agency in Marvel Comics * Crime Syndicate of Amer ...

and therefore remains unregulated as a drug of abuse.

References

Hypnotics GABAA receptor positive allosteric modulators Alkyne derivatives Vicinal diols Phenyl compounds {{sedative-stub